COGT
Price
$13.08
Change
+$1.08 (+9.00%)
Updated
Sep 3 closing price
Capitalization
1.83B
74 days until earnings call
INBX
Price
$27.80
Change
+$0.18 (+0.65%)
Updated
Sep 3 closing price
Capitalization
402.69M
70 days until earnings call
Interact to see
Advertisement

COGT vs INBX

Header iconCOGT vs INBX Comparison
Open Charts COGT vs INBXBanner chart's image
Cogent Biosciences
Price$13.08
Change+$1.08 (+9.00%)
Volume$3.58M
Capitalization1.83B
Inhibrx Biosciences
Price$27.80
Change+$0.18 (+0.65%)
Volume$80.65K
Capitalization402.69M
COGT vs INBX Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. INBX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and INBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (COGT: $13.08 vs. INBX: $27.80)
Brand notoriety: COGT and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 127% vs. INBX: 68%
Market capitalization -- COGT: $1.83B vs. INBX: $402.69M
COGT [@Biotechnology] is valued at $1.83B. INBX’s [@Biotechnology] market capitalization is $402.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileINBX’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • INBX’s FA Score: 1 green, 4 red.
According to our system of comparison, INBX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 3 TA indicator(s) are bullish while INBX’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 3 bullish, 4 bearish.
  • INBX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, INBX is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +5.74% price change this week, while INBX (@Biotechnology) price change was +1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

INBX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.83B) has a higher market cap than INBX($403M). INBX YTD gains are higher at: 80.519 vs. COGT (67.692). INBX has higher annual earnings (EBITDA): -155.08M vs. COGT (-299.34M). COGT has more cash in the bank: 238M vs. INBX (187M). COGT has less debt than INBX: COGT (60.7M) vs INBX (107M). INBX has higher revenues than COGT: INBX (1.4M) vs COGT (0).
COGTINBXCOGT / INBX
Capitalization1.83B403M453%
EBITDA-299.34M-155.08M193%
Gain YTD67.69280.51984%
P/E RatioN/A0.20-
Revenue01.4M-
Total Cash238M187M127%
Total Debt60.7M107M57%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTINBX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 29 days ago
83%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIFLX15.580.04
+0.26%
Lord Abbett Focused Large Cap Value I
AFOIX19.490.03
+0.15%
Alger Mid Cap Focus I
FCPIX36.99N/A
N/A
Fidelity Advisor Intl Cap App I
CRBRX13.83-0.01
-0.07%
Columbia Acorn Inst2
FRBAX30.55-0.04
-0.13%
JHancock Regional Bank A

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+9.00%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-8.42%
CGON - COGT
50%
Loosely correlated
+4.41%
IDYA - COGT
50%
Loosely correlated
+1.10%
ATXS - COGT
50%
Loosely correlated
+6.07%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with COGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+0.65%
COGT - INBX
41%
Loosely correlated
+9.00%
ACET - INBX
38%
Loosely correlated
-0.60%
STOK - INBX
37%
Loosely correlated
+0.92%
IPSC - INBX
36%
Loosely correlated
-1.60%
ZYME - INBX
36%
Loosely correlated
+0.93%
More